Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Sales      
Total sales $ 250,440 $ 264,315 $ 286,020
Cost of goods sold 167,464 171,696 188,509
Gross profit 82,976 92,619 97,511
Operating expenses      
Selling, general and administrative 105,173 111,948 114,603
Restructuring charges 967 1,948 3,223
Transaction costs 752 576 593
Contingent consideration benefit (355) (125) (1,565)
Legal costs and regulatory matter expenses 4,682 3,842 1,764
Impairment of goodwill 3,804 36,264 0
Impairment of indefinite-lived intangible assets 27,634 8,545 0
Total operating expenses 142,657 162,998 118,618
Operating loss (59,681) (70,379) (21,107)
Other income (expense)      
Interest income, net 619 1,467 67
Other, net 1,973 (1,673) 961
Total other income (expense), net 2,592 (206) 1,028
Loss before income tax (57,089) (70,585) (20,079)
Income tax (benefit) expense (10,533) 17,852 (4,291)
Loss from continuing operations (46,556) (88,437) (15,788)
Discontinued operations, net of tax   36,150 5,642
Net loss (46,556) (52,287) (10,146)
Other comprehensive income (loss), net of tax:      
Foreign currency translation adjustment 8,172 (9,635) 2,405
Unrealized (loss) gain on hedging activities (329) 517 (134)
Other comprehensive income (loss) 7,843 (9,118) 2,271
Comprehensive loss $ (38,713) $ (61,405) $ (7,875)
Loss from continuing operations per share:      
Basic $ (1.21) $ (2.31) $ (0.42)
Diluted (1.21) (2.31) (0.42)
Net loss per share:      
Basic (1.21) (1.37) (0.27)
Diluted $ (1.21) $ (1.37) $ (0.27)
Weighted average shares outstanding:      
Basic 38,393 38,305 37,485
Diluted 38,393 38,305 37,485
Domestic sales      
Sales      
Total sales $ 106,123 $ 105,745 $ 112,385
International sales      
Sales      
Total sales $ 144,317 $ 158,570 $ 173,635